Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 7, 2009

GenOway to Provide Beth Israel Deaconess Medical Center with Transgenic Rodents

  • genOway has been signed up to provide the Beth Israel Deaconess Medical Center (BIDMC) with genetically modified rodents for its medical research. The deal takes the form of a two-year, renewable-framework agreement.

    genOway is a service provider dedicated to the development of genetically modified mouse and rat models. The company’s technologies include its Safe DNA Transgenesis™, Safe RNAi Transgenesis™, Safe in vivo RNAi™, and Quick Knock-in™ platforms.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »